Recent Jobs

  • Regulatory Affairs Manager – CMC

    Regulatory Professionals
    Suffolk, Norfolk, Huntingdonshire, Hertfordshire, Essex, Cambridgeshire, Bedfordshire, >UK
    • FULL TIME
  • Regulatory Affairs Officer

    Regulatory Professionals
    East Anglia, Cambridgeshire, >UK
    • FULL TIME
  • Artwork Co-ordinator

    Regulatory Professionals
    Middlesex, >UK
    • FULL TIME
  • Regulatory Affairs Manager/Senior

    Regulatory Professionals
    Wiltshire, Hampshire, Gloucestershire, Berkshire, >UK
    • FULL TIME
Load more listings

Featured Job

Regulatory Affairs Manager – CMC

Reference Number: J30011 Regulatory Affairs Manager – CMC Midlands & SE England Salary: Competitive + Benefits Regulatory Professionals are currently

Make your job search easier

Create a candidate account to save jobs for later and have the latest roles and career advice emailed to you.

Register for Job Alerts

Create an Account

Complete your online profile and make it easier to apply for roles on the move.

Register your Details

Want to see how you compare to the rest of the industry?

Enter your details to receive a complimentary copy of our salary guide delivered to your door.

Life Science Salary Guide

Regulatory Professionals is one of the fastest growing global integrated regulatory outsourcing providers with a network of 20,000 pharmaceutical professionals globally. Working exclusively within the regulatory functions of Pharmaceutical, Biotechnology, Medical Device, Consumer health / OTC and Diagnostics industries.

Our integrated regulatory affairs recruitment team is there to support partner organisations of all sizes. Ranging for one regulatory consultant, to deliver a specialist project, to outsourcing functional regulatory teams of over 100+, Regulatory Professionals are able to offer global support partnered with expert local knowledge. Our capabilities also offer contract and permanent regulatory staffing services to allow a 360 degree service range for all aspects of regulatory delivery.

Our regulatory recruitment teams approach is tailored to meet the needs of our partners requirements allowing you to shift internal R&D focus to more strategic activities to improve lifecycle performance.

The benefits of Regulatory Professionals integrated teams are measured not just in the savings that could result in multi-mullion dollar cost reductions, but equally in understanding that delays in any part of the regulatory cycle affect the ability to give patients access to transformational products.

Our integrated teams support your product portfolio by giving you flexibility of resource at the peaks and troughs of the product life cycle, while ensuring you maintain control of strategic regulatory departments. This is supported by consistent, measurable and tracked metrics to maximise accountability.

To find out more about each of the regulatory areas we specialise in, take a look at the following regulatory recruitment services:

•    Regulatory Medical Devices
•    Regulatory Clinical
•    Regulatory CMC
•    Regulatory Submissions and Publishing
•    Regulatory Writing
•    Lifecycle Management

Our experienced specialist recruitment consultants are available to speak to you confidentially about our outsourcing regulatory affairs services. To find out more information or to discuss any of our regulatory vacancies, please call our specialist regulatory affairs recruitment team.

+44 (0)118 9522 797

Contact us today to find out how we can progress your career to the next level

Latest News

lung xray

FDA approval GSK’s triple therapy inhaler for COPD

FDA has recently approved GSK’s triple therapy inhaler, the news follows on shortly from an EMA CHMP positive opinion and the FDA advisory panel’s recent nod for its shingles vaccine, Shingrix. The news was highly welcomed, especially in the chronic obstructive pulmonary disease (COPD) area, as the current major seller in the area, Advair, faces

Continue Reading

lung xray

Fast track designation given to Shire’s chronic lung disease drug by FDA

The Food and Drug Administration has approved Fast Track designation for Shire’s SHP607, a treatment used in the prevention of chronic lung disease in extremely premature infants. SHP607, which is currently in Phase 2 Clinical Development, is a recombinant human version of the naturally occurring protein complex of insulin-like growth factor 1 (IGF-1) and its

Continue Reading